AQR Arbitrage LLC - EUCRATES BIOMEDICAL ACQU COR ownership

EUCRATES BIOMEDICAL ACQU COR's ticker is EUCRW and the CUSIP is G3141W122. A total of 20 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
AQR Arbitrage LLC ownership history of EUCRATES BIOMEDICAL ACQU COR
ValueSharesWeighting
Q1 2023$1,856
-20.6%
45,8320.0%0.00%
Q4 2022$2,337
+16.8%
45,8320.0%0.00%
Q3 2022$2,000
-33.3%
45,8320.0%0.00%
Q2 2022$3,000
-62.5%
45,8320.0%0.00%
Q1 2022$8,000
-98.2%
45,8320.0%0.00%
-100.0%
Q4 2021$447,000
+1254.5%
45,8320.0%0.01%
+1000.0%
Q3 2021$33,00045,8320.00%
Other shareholders
EUCRATES BIOMEDICAL ACQU COR shareholders Q4 2021
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 66,666$651,0000.02%
Altium Capital Management LP 133,333$77,0000.02%
Granite Point Capital Management, L.P. 133,332$77,0000.01%
AQR Arbitrage LLC 45,832$447,0000.01%
Radcliffe Capital Management, L.P. 33,333$325,0000.01%
COWEN AND COMPANY, LLC 178,347$103,0000.01%
CVI Holdings, LLC 118,333$69,0000.01%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 333,333$193,0000.00%
KINGDON CAPITAL MANAGEMENT, L.L.C. 66,665$36,0000.00%
683 Capital Management, LLC 200,000$116,0000.00%
View complete list of EUCRATES BIOMEDICAL ACQU COR shareholders